|
Case
|
Result of preoperative CNB
|
Final pathology
|
Method of surgery
|
Chemotherapy
|
Radiotherapy
|
Endocrine therapy
|
Follow-up (months)
|
Recurrence
|
|---|
|
1
|
IDP
|
AME carcinoma
|
WLE
|
−
|
+
|
Tamoxifen
|
105
|
−
|
|
2
|
IDC
|
AME carcinoma with DCIS
|
BCS, SLNB
|
−
|
+
| |
105
|
−
|
|
3
|
AME tumor
|
AME carcinoma
|
TM, SLNB
|
Adjuvant AC 4 cycles
|
−
| |
72
|
−
|
|
4
|
AME carcinoma
|
AME carcinoma
|
WLE, SLNB
|
Adjuvant TAC 6 cycles
|
+
| |
37
|
−
|
|
5
|
AME neoplasm
|
AME carcinoma
|
WLE
|
−
|
+
| |
33
|
−
|
|
6
|
Eccrine spiradenoma
|
AME carcinoma
|
WLE
|
−
|
−
| |
20
|
−
|
|
7
|
Papillary neoplasm
|
AME carcinoma
|
WLE, SLNB
|
−
|
+
|
Tamoxifen
|
14
|
−
|
|
8
|
AME carcinoma
|
AME carcinoma
|
WLE
|
−
|
+
|
Tamoxifen
|
8
|
−
|
|
9
|
IDC
|
AME carcinoma
|
BCS, SLNB
|
−
|
+
| |
54
|
−
|
|
10
|
Papillary neoplasm
|
AME carcinoma
|
WLE
|
−
|
+
|
Tamoxifen
|
45
|
−
|
|
11
|
AME neoplasm
|
AME carcinoma
|
WLE
|
−
|
+
| |
33
|
−
|
|
12
|
AME neoplasm
|
AME carcinoma
|
WLE
|
−
|
+
| |
162
|
Local recurrence, lung metastasis
|
|
13
|
Sclerosing adenosis
|
AME carcinoma
|
WLE
|
−
|
−
| |
111
|
−
|
|
14
|
Papillary neoplasm
|
AME carcinoma
|
WLE
|
−
|
−
| |
5
|
−
|
|
15
|
IDC
|
AME carcinoma
|
TM, SLNB
|
Neoadjuvant AC 4 cycles
|
−
|
Tamoxifen
|
24
|
Lung metastasis
|
- AME Adenomyoepithelial, IDP Intraductal papilloma, IDC Invasive ductal carcinoma, WLE Wide local excision, BCS Breast conserving surgery, SLNB Sentinel lymph node biopsy, TM Total mastectomy, AC Adriamycin, cyclophosphamide, TAC Docetaxel (Taxotere), adriamycin, cyclophosphamide
